Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Progenesis Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Progenesis Technologies

Progenesis Technologies

Progenesis Technologies: Innovating in bacterial alginate research for industrial, medical, and defense applications since 2006.

HQ
South Charleston, WV, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Progenesis Technologies, LLC, founded in 2006, is dedicated to the research, development, and commercialization of genetically-engineered bacterial alginates. The company's core mission is to innovate and provide advanced solutions for industrial, medical, and defense applications. Their product offerings include absorbent bacterial alginate for moisture control in sanitary pads and agricultural/home gardening markets, as well as genetically engineered bacterial alginate for radioisotope decontamination, catering to military, homeland security, and civil defense needs.

Notable affiliated individuals and investors have not been disclosed publicly. Key achievements include the successful development of specialized bacterial alginates that address critical needs across diverse sectors. Progenesis Technologies has made a significant impact by providing cutting-edge biotechnological solutions that enhance safety and efficiency in both civilian and defense contexts.

Progenesis Technologies - Similar Companies

EndGenitor Technologies logo

EndGenitor Technologies

Conagen logo

Conagen

Iogenetics logo

Iogenetics

iogenetics.com

Pathogenetix logo

Pathogenetix

Evogen logo

Evogen

evogen.com

GeniPhys logo

GeniPhys

geniphys.com

Proteogenix logo

Proteogenix

Mogene logo

Mogene

mogene.com

GenPrime logo

GenPrime

genprime.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

AgThera logo

AgThera

agthera.com

Algaeon logo

Algaeon

Transomic Technologies logo

Transomic Technologies

Alpha Genesis logo

Alpha Genesis

Auxergen logo

Auxergen

auxergen.com

Progenesis Technologies - Quick Facts

Who are Progenesis Technologies' competitors?

Companies similar to Progenesis Technologies include EndGenitor Technologies, Conagen, Iogenetics and Pathogenetix.

When was Progenesis Technologies founded?

Progenesis Technologies was founded in 2006.

Where is Progenesis Technologies' headquarters located?

Progenesis Technologies' headquarters is located in South Charleston, WV, US.

When was Progenesis Technologies' last funding round?

Progenesis Technologies' most recent funding round was for $100k (USD) in July 2010.

How much has Progenesis Technologies raised to-date?

As of Jul 15, 2010, Progenesis Technologies has raised a total of $100k (USD).

How many employees does Progenesis Technologies have?

Progenesis Technologies has 30 employees as of Feb 5, 2024.

Progenesis Technologies - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Alginate Products
Tags
  • AgTech
  • Biotech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified